Adam Palasciano is a writer over three years of experience writing about personal finance, investing, student loans, and more, for outlets like GOBankingRates, FinanceBuzz, The Penny Hoarder, and Wall ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

JPMorgan upgraded Recursion Pharmaceuticals (RXRX) to Overweight from Neutral with a price target of $11, up from $10. The firm says the company’s REC-4881 has shown “strong and durable” efficacy in ...

Contrary to a common assumption, you don't need a ton of capital to get started as an investor. Plenty of average earners have grown their retirement savings to seven-figure sums. The key is letting ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Buffett attributes his wealth to opportunity, privilege, and long-term compounding. Growing up in the U.S. gave him access to a successful market system and economic mobility. He describes being born ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

You’re more likely to find rates below 5% when you have a higher credit score Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor for Buy Side ...

WASHINGTON, DC - JUNE 18: Federal Reserve Board Chairman Jerome Powell holds a news conference following a Federal Open Market Committee meeting on June 18, 2025 in Washington, DC. Despite President ...

The Bank of Japan moved to slow inflation as the prime minister is borrowing more to fund an ambitious effort to build up industry and support households. By River Akira Davis Reporting from Tokyo ...

TOKYO, Dec 19 (Reuters) - The Bank of Japan raised interest rates on Friday to levels unseen in 30 years, taking another landmark step in ending decades of huge monetary support and near-zero ...

The Federal Reserve’s final monetary move of 2026 gave markets a clearer but still-incomplete vision of where interest rates might be heading next year—a year likely marked by continued concerns over ...